Study: Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance
18 Sep, 2017 | 13:56h | UTCEffects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Commentary: Acarbose Offers No CVD Protection in ACE, but May Cut Diabetes Risk – Medscape (free registration required)